Acutus Medical Stock Alpha and Beta Analysis
| AFIB Stock | USD 0 0.0009 30.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Acutus Medical. It also helps investors analyze the systematic and unsystematic risks associated with investing in Acutus Medical over a specified time horizon. Remember, high Acutus Medical's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Acutus Medical's market risk premium analysis include:
Beta 20.87 | Alpha 64.72 | Risk 251.51 | Sharpe Ratio 0.27 | Expected Return 67.97 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Acutus |
Acutus Medical Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Acutus Medical market risk premium is the additional return an investor will receive from holding Acutus Medical long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Acutus Medical. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Acutus Medical's performance over market.| α | 64.72 | β | 20.87 |
Acutus Medical expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Acutus Medical's Buy-and-hold return. Our buy-and-hold chart shows how Acutus Medical performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Acutus Medical Market Price Analysis
Market price analysis indicators help investors to evaluate how Acutus Medical pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Acutus Medical shares will generate the highest return on investment. By understating and applying Acutus Medical pink sheet market price indicators, traders can identify Acutus Medical position entry and exit signals to maximize returns.
Acutus Medical Return and Market Media
The median price of Acutus Medical for the period between Fri, Sep 26, 2025 and Thu, Dec 25, 2025 is 5.0E-4 with a coefficient of variation of 96.81. The daily time series for the period is distributed with a sample standard deviation of 0.0, arithmetic mean of 0.0, and mean deviation of 0.0. The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About Acutus Medical Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Acutus or other pink sheets. Alpha measures the amount that position in Acutus Medical has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Acutus Medical Upcoming Company Events
As portrayed in its financial statements, the presentation of Acutus Medical's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Acutus Medical's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Acutus Medical's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Acutus Medical. Please utilize our Beneish M Score to check the likelihood of Acutus Medical's management manipulating its earnings.
| 21st of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 30th of September 2023 Last Quarter Report | View |
Build Portfolio with Acutus Medical
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Other Information on Investing in Acutus Pink Sheet
Acutus Medical financial ratios help investors to determine whether Acutus Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Acutus with respect to the benefits of owning Acutus Medical security.